A carregar...
HIF1A is a critical downstream mediator for hemophagocytic lymphohistiocytosis
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening syndrome characterized by overwhelming immune activation. A steroid and chemotherapy-based regimen remains as the first-line of therapy but it has substantial morbidity. Thus, novel, less toxic therapy for HLH is urgently needed. Althoug...
Na minha lista:
Publicado no: | Haematologica |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Ferrata Storti Foundation
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5664400/ https://ncbi.nlm.nih.gov/pubmed/28860338 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2017.174979 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|